Key changes to the AIM Rules
Following on from last year’s discussion paper and the subsequent consultation on changes to the AIM Rules, the details of which were discussed in our November 2017 Public Company Update, the Exchange has proceeded to make a number of amendments to the AIM Rules for Companies and the AIM Rules for Nominated Advisers, the details of which are set out in AIM Notice 50.
Formalisation of the early notification process
With effect from 30 March 2018, Nomads are now required to enter into confidential discussions with the Exchange early in the listing process in order to highlight atypical features or potential issues that may be of concern to the Exchange in connection with a potential AIM applicant.
The revised AIM Rules for Nominated Advisers at Schedule Three sets out a non-exhaustive list of matters entitled “Guidance to Admission Responsibilities” any of which could potentially mean that an applicant’s appropriateness for AIM is questionable. These matters include where there are questions as to the character, skills or experience of directors, where there are unusual corporate structures or the company owns assets via contractual arrangements rather than directly and the general appropriateness of the applicant for the public markets in the UK.
The early notification form asks basic questions which align to those Admission Responsibilities – so covers the applicant’s corporate structure, details of advisers to the transaction, qualifications to last audited accounts, target fund raise, anticipated free-float, details of all directors, applicable employees and significant shareholders, and a catch-all question as to whether there are “any other matters concerning the appropriateness of the applicant which may have the potential to be detrimental to the orderly operation, the reputation and/or integrity of AIM”.
The Nomad community’s general view, which we share, is that formalising the early notification process is a good move as it will help identify any potential red flags at an early stage thereby giving a better level of deal certainty. It is certainly preferable that queries the Exchange has arising from the form are known earlier on in the transaction so they can be dealt with or cleared in good time rather than nearer to Admission.
With effect from 28 September 2018 it will be mandatory for AIM companies to adopt a corporate governance code and to explain how they comply (or where they do not do so, to explain why) against a recognised corporate governance code. This will replace the current regime which simply requires consideration of corporate governance as part of the appropriateness review and then disclosure of an issuer’s corporate governance regime.
AIM Rule 26 has accordingly been amended to require AIM companies’ websites to contain details of the governance code that the board has decided to apply, how the AIM company complies with that code, and where it departs from its chosen corporate governance code an explanation of the reasons for doing so. This information is required to be reviewed annually and the disclosure on the website must include the date on which this information was last reviewed.
New applicants to AIM from 30 March 2018 are required to state on their website which code they intend to follow but will otherwise have until 28 September 2018 to comply.
There is no list of “recognised corporate governance codes” but in reality for most issuers, perhaps with the exception of those which are incorporated and have a primary listing in jurisdictions other than the UK, the choice will be between the UK Corporate Governance Code published by the Financial Reporting Council and the QCA Corporate Governance Code published by the Quoted Companies Alliance. In fact AIM Notice 50 highlights both of those codes as examples.
For more information, please cotact Paul Arathoon.
Phase out of temporary restrictions on use of winding up petitions
Hannah takes a look at the recent UK Government announcement on statutory demands and the presentation of winding up petitions
Preparing your company for sale
We set out here some initial steps to consider in anticipation of a sale.
Overhaul of London's stock market listing regime set to significantly boost capital raising opportunities for founder led UK tech businesses
Charles Russell Speechlys advises discoverIE on its acquisition of Antenova
discoverIE is a leading international designer, manufacturer and supplier of customised electronics to industry.
Charles Russell Speechlys advises Acora on acquisition of Westgate IT
Westgate IT specialises in providing IT support to businesses in the South West.
Charles Russell Speechlys advises Grape Paradise on the acquisition of a fine wine business
Charles Russell Speechlys has advised Grape Paradise on the acquisition of the Sarment Group in the China Mainland territories.
Ongoing supply chain crisis looms large over upcoming allergen law change
The Business Magazine and The Surrey Chambers of Commerce report on the firm's involvement in the sale of Online Fuels Limited to DTN
The firm advised the shareholder management team on the sale of shares in Online Fuels to global data, analytics, and technology group, DTN.
Charles Russell Speechlys advises Appital Ltd on £2.5m Investment led by Frontline Ventures
Appital is an Equity Capital Marketplace which aims to bring innovation to Equity Capital Markets.
The Business Magazine, Insider Media, Business South and The Surrey Chambers of Commerce report on the firm's involvement in Appital's £2.5m growth capital investment
The injection will accelerate the development of Appital’s technology infrastructure, integration with financial institutions.
Healthcare team advises Country Court Care on £57m sale of three care homes
Country Court Care Group Ltd has been active almost 35 years as a nursing and care home operator.
Pei Li Kew
B[re]aking up is never easy... a lesson from the Oetker business split
Charles Russell Speechlys advises Metier on US$39m investment into Africa Mobile Networks
AMN builds, owns, operates and maintains mobile network infrastructure in Africa.
Charles Russell Speechlys advises Apposite Capital on acquisition of i2a Diagnostics
i2a is a leading provider of laboratory instruments, software and reagents for the clinical microbiology market in France.
Brace yourselves: dentists could be liable for actions of self-employed staff
Private companies and public interest – a new approach to corporate governance?
Is now the optimal time to sell your company?
Charles Russell Speechlys advises Duke Royalty on royalty financing agreement with Fairmed Healthcare AG
Duke Royalty is the leading provider of royalty finance to companies in the UK and Europe.
Charles Russell Speechlys shortlisted for Best EIS/SEIS Legal/Regulatory Adviser at 2021 EISA Awards
The Awards denote excellence and recognise the achievements of EIS/SEIS practitioners over the past year.
COVID-19 Vaccination – can an employer make it compulsory for employees?
We review what legal issues to take into account when considering to make vaccination compulsory as an employer.